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Abstract
In computational science literature including e.g., bioinformatics, computational statistics
or machine learning, most published articles are devoted to the development of “new
methods”, while comparison studies are generally appreciated by readers but surprisingly
given poor consideration by many journals. This paper stresses the importance of neutral
comparison studies for the objective evaluation of existing methods and the establishment
of standards by drawing parallels with clinical research.
The goal of the paper is two-folded. Firstly, we present a survey of recent computa-
tional papers on supervised classification published in seven high-ranking computational
science journals. The aim is to provide an up-to-date picture of current scientific practice
with respect to the comparison of methods in both articles presenting new methods and
articles focusing on the comparison study itself. Secondly, based on the results of our
survey we critically discuss the necessity, impact and limitations of neutral comparison
studies in computational sciences. We define three reasonable criteria a comparison study
has to fulfill in order to be considered as neutral, and explicate general considerations on
the individual components of a “tidy neutral comparison study”.
R codes for completely replicating our statistical analyses and figures are avail-
able from the companion website http://www.ibe.med.uni-muenchen.
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de/organisation/mitarbeiter/020_professuren/boulesteix/
plea2013.
1 Introduction
The main goal of methodological research in computational sciences (including, e.g.
bioinformatics, machine learning, or computational statistics) is the development of new
methods. By development of new methods, we mean that the researchers suggest new
procedures for analyzing data sets. The new procedure should be applicable to specific
substantive research questions, but these substantive research questions (often) are not the
primary center of interest of the methodological researcher. New methods are expected
to “make the world better” by, roughly speaking, making the results of statistical anal-
yses closer to the truth. Surprisingly, comparison studies and reviews investigating the
closeness to the truth are sometimes considered as less exciting and less useful by many
researchers or by most journal editors, and often implicitly excluded from the journals’
scopes.
This is in strong contrast to clinical research. The ultimate goal in clinical research
is to make the world better by somehow improving the health outcome of patients (or
reducing the cost while maintaining the same outcome), for instance through a specific
drug, therapy or prevention strategy. Roughly speaking, the clinical analogue of a com-
putational article suggesting a new method would be an article suggesting a new interven-
tion for improving health outcome. Yet, most published medical papers do not directly
suggest such a new measure. Many other types of clinical research projects are con-
ducted, for instance large validation studies, phase IV clinical trials, or meta-analyses.
Of course, crucial differences between computational science research and medical re-
search make comparisons only partially pertinent. Research on algorithms and methods
does not follow the same rules as research involving human beings with direct potentially
vital consequences. The development of a new drug or new prevention strategy essen-
tially requires more time, money, coordination and caution than the development of a new
statistical method. Some principles, however, hold for both worlds. If we focus on the
problem of comparison studies considered in this paper, the question is whether we can
imagine a world in which clinical journals accept to publish only underpowered phase
I or II clinical trials evaluating new therapies but no phase III or IV trials. The answer
is of course no. In data analysis journals, however, the equivalent of phase III and IV
trials, i.e. well-conducted comparison studies in our metaphor, are often considered as
not deserving publications. Note that the importance of comparison studies and their lack
of consideration in the literature is not specific to computational science and has been
2
recognized in other fields such as experimental biosciences [4].
We claim that comparison studies in computational sciences may be necessary to en-
sure that previously proposed methods work as expected in various situations and that
emerging standard practice rules adopted by substantive researchers or statistical consul-
tants are the result of well-designed studies performed by computational science experts.
The community tends to establish standards and guidelines as time goes by. In an ideal
world, these standards are the results of well-done comparative studies and consensus
from independent teams. However, other factors might contribute to promote a partic-
ular method, including the reputation of the authors or the impact factor of the journals
the method was published in. From the point of view of applicants (say, for example,
biologists), further criteria include the availability of well-documented and user-friendly
implementations of the method or an application of this method in one of the few leading
scientific journals that other scientists tend to imitate. These quantitative objective crite-
ria may seem natural. After all, a method published by a renown author in an excellent
journal is more likely to work well than a method published by an unknown author in a
low-ranking journal. Availability of good software is of course a crucial advantage for
applicants who would not be able or would not have the time to implement any of the
methods themselves. And a method that worked well in a previous well-published study
is perhaps more likely to also work well in future studies than another method.
It is unclear, however, whether standard practice rules should be established solely
on such subjective criteria. Would it not be better to give more importance to compari-
son studies? One may of course argue that comparison studies can be performed within
original articles presenting new methods. Indeed, in practice new methods are usually
compared to a few existing methods in order to establish their superiority. Such com-
parison studies are extremely important for illustrative purposes, i.e. to demonstrate that
the developed method is applicable in practice and yields acceptable results, but should
strictly speaking not be considered as comparison studies because they are often substan-
tially biased and thus not neutral.
For example, in the context of clinical outcome prediction or diagnosis based on high-
dimensional “omics” data (such as, e.g. microarray gene expression data), hundreds of
articles presenting new supervised classification algorithms have been published in the
bioinformatics, statistics and machine learning literature. Almost all of them claim that
the new method “performs better” than existing methods. Most often these claims are
based on small real data studies including a few exemplary data sets. The fact that for
twelve years hundreds of authors have been claiming that their new method for classifica-
tion using microarray data outperforms existing ones suggests that something goes wrong
in the comparison studies performed in these articles. Similar discussions can be found in
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other fields of application of machine learning and computational statistics [11].
In this paper we present a survey of recent computational papers on supervised clas-
sification published from 2010 to 2012 in seven high-ranking journals in the fields of
bioinformatics, computational statistics and machine learning. The goal of our survey
is to provide an up-to-date picture of current scientific practice with respect to the com-
parison of methods in both articles presenting new methods and articles focusing on the
comparison study itself. To keep the survey feasible, the focus is set on supervised classi-
fication, a topic within our own area of expertise that is highly relevant in bioinformatics,
computational statistics and machine learning.
We then take the results and insights given by the survey as a starting point to critically
discuss the necessity, impact and limitations of neutral comparison studies in computa-
tional sciences. In particular, we define three reasonable criteria a comparison study has
to fulfill to be considered as neutral. Furthermore, we explicate general considerations on
the individual components of a “tidy neutral comparison study” and argue for the publi-
cation of negative results and pitfalls. We consequently draw parallels to clinical research
and clinical studies in order to motivate and illustrate our statements, decisions and argu-
ments.
2 Methods
We designed a study to provide an up-to-date quantitative picture of real data compari-
son studies presented as part of published papers with emphasis on neutrality issues and
whether the studies identify winners. Figure 1 visualizes the article selection process and
recording of comparison study features.
2.1 Research fields, journals and articles
Given the large number of research fields related to computational science, we decided
to focus on three fields in the area of our expertise and research interests: bioinformatics
(BI), computational statistics (CS) and machine learning (ML). We chose seven repre-
sentative high-ranking journals (Table 1 lists them), and restricted the survey to articles
published in these journals between 2010 and 2012.
The defined survey setting results in a total set of 5100 articles. We then conducted
a manual screening of the articles based on their titles to select those dealing with su-
pervised classification, i.e., from a statistical point of view, regression for categorical
dependent variables. A manual screening was preferred to a systematic database search
based on keywords, because we realized in a small pilot study that many articles do not
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mention supervised learning or classification as keywords or in the title but, for example,
rather the name of the specific learning method which is considered.
2.2 Inclusion criteria
The goal of the study is to explore common scientific practice in comparing supervised
classification methods. Therefore, for each article related to supervised classification we
first report
1. whether the article presents a comparison study comparing two or more methods.
Comparison studies can be executed on simulated/artificial data or so-called “real world”
data. This could make a difference for the inference of “standard practice rules”, since
real world data are known to often behave differently from simulated data; therefore, we
report
2. whether the article includes an evaluation on real data.
Since one of our main claims in the paper is that comparison studies are important to infer
“standard practice rules” we focus the survey on articles fulfilling both Condition 1 and
Condition 2; therefore, we report for each article
3. whether the article includes an evaluation of two or more methods on real data.
2.3 Comparison study features
We designed the following eight observable comparison study features to capture infor-
mation on common practice in the context of comparison studies based on real data. To
address the issue of neutrality (which is essentially a latent unobservable variable), we
particularly focused on the differentiation between comparison studies published as part
of a paper introducing a new method and comparison studies on existing methods whose
contribution is the comparison itself.
Basic features. For each comparison study we recorded the following basic features:
1. Number of considered real data sets
2. Number of considered methods/variants
3. Number of accuracy measures
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Purpose of a comparison study. Comparison studies can be executed for two differ-
ent purposes: to illustrate a newly developed method and compare it against established
competing methods, or to compare existing methods in a more “symmetric approach” in
order to provide recommendations for substantive researchers who want to analyse the
data they produced. Therefore, we report
4. whether the purpose of the comparison study is to introduce a new method or to
compare existing ones;
Reported main results. Based on the conclusion drawn by the authors (i.e. without
looking ourselves at the figures reported in the paper), we report
5. whether the comparison study identifies one or several methods as (a) clear win-
ner(s) according to the conclusion section, and if yes,
6. whether the winners, if any, are mentioned in the abstract;
Introduction of a new method. If the comparison study focuses on the introduction of
a new method, we report
7. whether the new method belongs to the identified winners (the answer “no” would
imply a “negative result”) and if yes, which type of winner(s) it is (see the definition
of winner categories in the Results section);
8. whether there are several variants of the method presented.
3 Results
In this section we present some results of the survey. Note that all re-
sults can be reproduced using R-codes and data available from the com-
panion website http://www.ibe.med.uni-muenchen.de/organisation/
mitarbeiter/020_professuren/boulesteix/plea2013, following recom-
mendations for computational reproducibility of research papers [6].
3.1 Articles
The initial situation was a population of n = 5100 articles published in the three com-
putational science fields bioinformatics (BI), computational statistics (CS) and machine
learning (ML).
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The manual screening identified n = 62 articles based on their titles. The word “clas-
sification” or “classifier” was found in 40 of these titles, while 24 titles included the name
of a specific method. The words “comparison” and “comparative” were found in four
titles. The word “prediction” also appeared in four titles, while the words “learning” and
“discrimination” were found in five titles and two titles, respectively. Three papers were
excluded after further consideration because they did not fit our definition of supervised
classification in spite of their title, finally yielding a total of n = 59 papers. Their refer-
ences can be found in the supplementary file.
Out of these n = 59 articles, n = 58 articles presented a comparison of two or more
methods as displayed in Figure 2A and Figure 2E. Three out of n = 59 articles did not
present any comparison study based on real data, as displayed in Figure 2B and Figure 2F.
This resulted in a total of n = 55 articles satisfying Condition 3, on which we focused in
the rest of our survey; see Figure 2C and Figure 2G.
Out of these 55 articles, 43 articles presented new methods and 12 articles presented
comparison studies of existing methods only, as shown in Figure 2D and Figure 2H.
3.2 Basic comparison study features
Each of the n = 55 articles fulfilling Condition 3 presented a comparison study of at least
two methods based on real data. We recorded the number of data sets, number of included
methods and number of accuracy measurements considered in each paper.
As can be seen from Figure 3A, the median number of data sets considered in the com-
parison studies was 5, while the mean was 5.86. When looking at the boxplots separately
per research field, see Figure 3D, the highest mean was found in the machine learning ar-
ticles with 6.64, while the medians vary from 2 in computational statistics to 6 in machine
learning. The maximal number of 21 data sets was found in a bioinformatics journal.
Figure 3B depicts the number of methods included in the comparisons. The median
was 6, while the mean was 6.36. A separate examination (Figure 3E) shows the high-
est median and mean for the machine learning papers with a median of 7 and a mean
of 7.2 included methods. The maximum of 20 included methods was again found in a
bioinformatics journal.
Finally, the mean number of accuracy measurements was 2.1 and the median was 2 as
depicted in Figure 3C, while the maximum of 8 accuracy measurements was found in the
machine learning articles (Figure 3F).
For illustrative purposes these basic features are also separately shown for the papers
presenting a new method and for papers focusing on the comparison itself. These boxplots
(Figure 3G, Figure 3H, Figure 3I) show that the number of data sets, number of methods
and number of accuracy measures were not substantially different for comparison studies
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and articles presenting new methods.
3.3 New methods and clear winners
A more delicate question is whether in comparison studies which introduce a new method
clear winner(s) among the considered methods are reported in the conclusion. Having
the so called “no-free lunch theorem” [12] in mind, we do not expect papers claiming
that one of the methods, for instance the new method, outperforms all competitors for all
classification problems.
We identified three main profiles: (W1) comparison studies claiming that the new
method outperforms the other methods in general with respect to the chosen accuracy
measure; (W2) comparison studies arguing that the new method shows performances
similar to existing methods in terms of accuracy but has either other important advan-
tages (for instance computational efficiency) or better performance in some specific cases
that makes it a serious competitor; and (W3) comparison studies just saying that the new
method performs similarly to other methods without pointing to a specific advantage.
Note that the classification of a comparison study into one of these categories implies
some subjectivity, since the definitions are intentionally kept vague. To make our clas-
sification more transparent, we give examples of typical statements for each of the three
categories in Table 2.
Five out of 12 comparison studies did not identify any clear winner(s) (see Figure 4A).
In contrast, all n = 43 papers presenting new methods belonged to one of these three cat-
egories W1, W2 or W3. Within these n = 43 papers, all three categories (W1, W2, W3)
had similar frequencies, with a slight advantage for W1 (see Figure 4C). The frequencies
of the three categories were not substantially different in bioinformatics, computational
statistics and machine learning journals (see Figure 4 G). The winner(s) was (were) often
mentioned in the abstract, especially in bioinformatics (see Figure 4B and 4F). In most
papers on new methods, several variants of the new method were considered (see Figure
4D and 4H).
As expected, no negative results were published, i.e., no paper suggested a new
method that finally turned out to perform worse than existing methods.
4 Discussion
In our survey based on n = 59 papers recently published in computational journals, we
observed that i) comparison studies published as part of papers presenting new methods
(n = 43) very often identify the new method(s) as (a) winner(s), while pure comparison
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studies (n = 12) do not always identify winners, ii) computational journals publish much
less pure comparison studies than new method papers, iii) papers suggesting new methods
are never negative with respect to the new method. In this section, we further reflect on
these three striking results by focusing on over-optimism issues and the need for neutral
comparison studies, by defining what we consider as a tidy neutral comparison study, and
by discussing the issue of negative findings.
4.1 Over-optimism and the need for neutral comparison studies
Comparison studies included in original research articles presenting new methods might
often be over-optimistic with respect to the superiority of the new method, as confirmed
by our survey that shows that new methods are often reported to be better than existing
methods in some sense, but never worse. Some reasons for over-optimism are empirically
assessed in detail in [8] and discussed in [1] in the context of supervised classification us-
ing high-dimensional molecular data. The first and perhaps most obvious reason for over-
optimism is that researchers sometimes “randomly search” for a specific data set such that
their new method works better than existing approaches, yielding a so-called data set bias
already investigated in the literature [13]. A second source of over-optimism, which is
related to the optimal choice of the data set mentioned above, is the optimal choice of a
particular setting in which the superiority of the new algorithm is more pronounced. For
example, researchers could report the results obtained after a particular feature filtering
which favors the new algorithm compared to existing approaches. The third and probably
most subtle problem is that researchers often tend to optimize their new algorithms to the
data sets they consider during the development phase [1, 8]. This mechanism essentially
affects all research fields related to data analysis such as statistics, machine learning, or
bioinformatics. Indeed, the trial-and-error process constitutes an important component of
data analysis research. As most inventive ideas have to be improved sequentially before
reaching an acceptable maturity, the development of a new method is per se an unpre-
dictable search process. The problem is that this search process leads to an artificial
optimization of the method’s characteristics to the considered data sets, as empirically
demonstrated in a study on supervised classification [8]. This optimization process over
different variants of the new method probably often partly takes place before publication
and thus remains confidential. It is common practice, however, to report the performance
of several variants in the final paper, as clearly shown by our survey. In both cases, the su-
periority of the novel method over an existing method (for instance as measured through
the difference between the cross-validation error rates) might be considerably overesti-
mated through this optimization process.
Other reasons are of technical nature and related to the ability of the researchers to
9
use the compared methods properly. For example, if an implementation problem occurs
with the competing approaches and slightly worsens their results, researchers often tend
to spontaneously accept these inferior results. Conversely, they would probably obsti-
nately look for the programming error if such problems occur with their new algorithm.
In the same vein, they may unintentionally set the parameters of competing methods to
sub-optimal values, or choose a variant of the method that is known by experts to be sub-
optimal. They may also select competing methods in a sub-optimal way, i.e. consciously
or subconsciously exclude the best methods from the comparison for any reason. Beyond
the problems of technical expertise and optimization bias, interpretation and representa-
tion issues might also affect the final conclusions of a comparison study. Given the same
quantitative outputs, the impression of the reader can be affected by the choice of the vo-
cabulary in the results section, by graphical representation, or by the choice of the main
quantitative criterion used to compare the methods.
For all these reasons, many comparison studies published in the literature as part of an
original paper are substantially biased. These problems stress the importance of neutral
comparison studies that we define as follows:
A. The main focus of the article is the comparison itself. It implies that the primary
goal of the article is not to introduce a new promising method.
B. The authors should be reasonably neutral. For example, an author who has pub-
lished an article on a new method six months before is likely to be less neutral
than an author who has often used several of the considered methods for statis-
tical consulting and, say, previously investigated three of them more precisely in
methodological articles. Although an informal check based on the authors’ publi-
cation lists found on their homepage suggested that it was not a problematic issue
for the n = 12 comparison studies included in our survey, non-neutrality of the
authors may induce a bias in general.
C. The evaluation criteria, methods, and data sets should be chosen in a rational way,
see Section 4 for a more extensive discussion of this problem.
Note that the comparison between the competing methods is essentially not affected
by the bias discussed in the introduction. Hence, a idea could be to extract neutral com-
parisons from comparison studies included in original articles presenting new methods –
by considering the competing methods only. However, one should keep in mind that these
methods probably have not been given as much attention as in the case of a real neutral
comparison study that does not involve any new method. This relative lack of attention
possibly leads the underestimation of their performance. In our survey, the number of
methods considered in the comparisons was not substantially lower for the n = 43 papers
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focusing on new methods and for the n = 12 comparison studies. This suggests that in
the former papers less attention is devoted to each compared method, since the authors
spend a lot of time on the development of the new method.
To come to the point, in an original article on a new method, the focus is on the new
method, and that is where the authors generally spend most of their energy. Consequently,
comparisons between competing methods should not be over-interpreted because they
may be of sub-optimal quality. On this account we make a (passionate) plea for neutral
comparison studies in computational sciences.
4.2 Tidy neutral comparison studies
In the same way clinical research and clinical studies have to be well planned and executed
(following strict guidelines), comparison studies should also follow a well-defined study
design. They should be based on a sound theoretical framework, appropriate analysis
methods, and carefully selected components. There is a variety of literature on the design
and analysis of comparison studies available – we propagate, for example, Hothorn et
al [7] as a theoretical framework and Eugster et al [5] as its practical implementation.
However, regardless of the concrete framework, general considerations on the individual
components – evaluation criteria, methods and method parameters, and data sets – can be
made.
• Choice of evaluation criteria: In the case of supervised learning algorithms, sim-
ple evaluation criteria are, among others, the error rate or preferably the area under
curve that is based on the predicted class probabilities. Such criteria are natural
and objective. Our survey showed that most published comparison studies consider
very few of these criteria, which can be seen as a weakness. However, many other
criteria have an impact on the usefulness of a method in practice for applications.
From a pedagogical point of view, one should not forget that the method is des-
tined to be used by experts or non-expert users. Therefore, all other things being
equal, simplicity of a method constitutes an important advantage, similarly to the
clinical context where the simplicity of a therapy protocol should be seen as a ma-
jor advantage. From a technical point of view, particular attention may be devoted
to computational aspects such as computation time and storage requirements (simi-
larly to the costs in the clinical context), the influence on initial values in an iterative
algorithm, or more generally the dependence on a random generator (similarly to
the robustness of the therapy’s effect against technical problems or human errors).
• Choice of methods and method parameters: The choice of methods is a very subjec-
tive one. At any rate, the concrete choice should be clearly motivated and personal
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preferences and similar influences should be clearly acknowledged. Researchers are
inevitably conducted by personal preferences, past experiences and own technical
competence, even if this aspect was not clearly apparent in the n = 12 compari-
son studies of our survey. However, the choice should also be guided by objective
arguments. Possible criteria are i) the popularity of the methods in practice (for
instance: restrict to methods that have been used in at least three concrete studies),
ii) results available from the literature (for example from a previous comparison
study) to pre-filter good candidates, or iii) specific pre-defined criteria specifying
the nature of the method, for example “only statistical regression-based methods”.
None of these criteria should be considered as mandatory for a neutral compari-
son study. But we claim that, the set of criteria being defined, the methods should
be more or less randomly sampled within the range of available methods. As far
as method parameters like hyperparameters are concerned, they should be chosen
based on “standard practice rules”.
• Choice of data sets: Researchers performing comparison studies also choose data
sets. Considering the high variability of relative performance across data sets and
the moderate number of data sets considered in each study (median number of 5 in
our survey), a comparison study based on different data sets may obviously yield
substantially different results. Variability arises both because error estimation with
standard resampling-based estimators is highly variable for a given underlying joint
distribution of predictors and response [3] and because different data sets also have
different underlying distributions. Therefore, it is important to make a selection of
data sets that is “as representative as possible” to cover the domain of interest. At
best, the data sets are chosen from a set of data sets representing the domain of
interest using standard sampling methodology.
In summary, many choices have to be met when performing a comparison study, for
example, in the case of supervised classification with high-dimensional data: the included
methods (e.g. penalized regression, tree ensembles, support vector machines, partial least
squares dimension reduction, etc), the considered variants (which kernel for SVM, which
fitting algorithm for penalized regression, which optimality criterion for PLS, which split-
ting criterion for tree ensembles, etc), the data domain (which type of data sets), the pa-
rameter tuning procedure (which resampling scheme, which candidate values). With this
in mind, it is clear that the topic of interest cannot be handled completely by a single
comparison study. Different comparison studies with similar scope may yield different
conclusions. This can be seen as a limitation of each single comparison study – or as
an argument to perform more such comparison studies. Going one step further in the
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comparison with clinical research, one could also imagine a concept of meta-analysis for
comparison studies in computational sciences. In the clinical context, meta-analyses pro-
vide a synthesis over different populations, different variants of the investigated therapies,
different technical conditions, different medical teams, etc. Similarly, meta-analyses for
computational studies in computational sciences would provide syntheses over different
data domains, different variants of the considered methods, different software environ-
ments, different teams with their own areas of expertise, etc.
4.3 Negative results and pitfalls
In our survey none of the 43 papers on new methods presented negative conclusions,
suggesting that computational literature is affected by a substantial publication bias. In
this context, neutral comparison studies can be a good vehicle for negative research find-
ings. Publication biases and the necessity to ”accentuate the negative” [10] are well-
documented in the context of medical and pharmaceutical research. In applied statistics
and data analysis research, however, this issue receives very poor attention [1], even if the
publication of negative results may be extremely useful in many cases.
The systematic exclusion of negative results from publication might in some cases
be misleading. For example, imagine that ten teams around the world working on the
same specific research question have a similar promising idea that in fact does not work
properly for any reason. Eight of the ten teams obtain disappointing results. The ninth
team sees a false positive in the sense that they observe significant superiority of the new
promising method over existing approaches although it is in fact not better. The tenth team
optimizes the method’s characteristics [8] and thus also observes significant superiority.
The two latter teams report the superiority of the promising idea in their papers, while the
eight other studies with negative results remain unpublished: a typical case of publication
bias. This scenario is certainly caricatural, but similar things are likely to happen in
practice although in a milder form. Note that it is very difficult to give concrete examples
at this stage, since such stories essentially remain unpublished.
Nevertheless, the publication of negative results might entail substantial problems.
Most researchers (including ourselves!) probably have more ideas that turn out to be dis-
appointing than ideas that work fine. Try-and-error is an essential component of research.
It would thus be impossible (and uninteresting anyway) to publish all negative results.
But then, what was promising and what was not promising? What is likely to interest
readers and what was just a bad idea that nobody else would have thought of? Obviously
this decision that would have to be taken by reviewers and editors is a subjective one.
Assessing whether a new method with negative results deserves publication in a separate
paper is anything but trivial. With this in mind, we believe that the publication of negative
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findings within large well-designed comparison studies would be a sensible compromise
in order to diffuse negative findings without congesting the literature with negative papers.
Journals would not have to fear for their impact, since good comparison studies are
usually highly accessed and cited. Authors would not be urged to make something out
of their promising idea on which they have spent a lot of time: a large comparison study
would be an alternative to publish important results and share their vast experience on the
topic without fishing for significance. And "fishing for significance" would lose part of
its attractiveness. Most importantly, readers would be informed about important research
activities they would not have heard of otherwise.
Note that “standard practice rules” in computational sciences (for example regarding
the choice of method parameters) are often implicitly the result of comparison studies.
For instance, a standard parameter value becomes standard because it yields better results
than another value. In other words, negative results are often hidden behind standard
practice rules - most of them remaining unpublished. Our point is that this process could
be made more transparent and more informative for the readers if these negative results
were published within extensive comparison studies.
Drawing the comparison with clinical research from the introduction even further,
we also think that it may be interesting to publish articles on pitfalls. By “pitfall” we
mean the inconveniences of a data analysis method such as, e.g., a non-negligible bias,
a particularly high variability, or non-convergence of an algorithm in specific cases that
may lead to misleading results. In computational literature such research results are often
hidden in the middle of articles that are actually devoted to something else. This is in
contrast to clinical research, where pitfalls of existing methods (for example an adverse
effect of a drug) may be the main object of an article, even if no alternative solution is
proposed (for example in form of an alternative drug).
5 Conclusion
Neutral comparison studies are in our opinion crucial to make the establishment of stan-
dards more objective and to give a chance to methods that are at first view unspectacular
and would otherwise be pigeonholed. They are probably not devoted enough attention in
the literature, as suggested by our survey that identified only 12 comparison studies out
of a total of 55 articles on supervised learning. However, comparison studies and their
impact should not be over-interpreted. Firstly, one should not forget that no method is
expected to work well with all data sets (the well-known “no free lunch theorem” [12]).
Hence, a method that scores well in many comparison studies may do poorly in a specific
data set. Comparison studies are not expected to yield an absolute truth applicable to all
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situations. They are solely useful to determine general trends that may be useful to the
community to select a set of standard methods that often perform well.
Secondly, comparison studies are essentially limited because they rely on the specific
and sometimes arbitrary choices regarding the study design: the choice of simplifying
evaluation criteria that probably do not reflect the complexity of concrete data analysis
situations, the choice of method parameters that may substantially impact the relative per-
formance of the considered methods, and last but not least the choice of specific example
data sets.
Thirdly, comparison studies are often underpowered in the sense that the number of
included data sets is insufficient considering the high variability of performance across
data sets. With a few exceptions (see the comparison of machine learning algorithms
based on 65 gene expression data sets [2]), comparison studies most often include up
to 10 data sets. The median number of considered data sets was only 5 in the n = 12
comparison studies considered in our survey. This is probably not enough. This issue
may be further investigated in future research.
Fourthly, comparison studies essentially ignore the substantive context of the data
sets they consider. Data sets are sometimes preprocessed without much knowledge of
the signification of the variables. All methods are applied in the same standardized way
to all data sets. The analysis is thus intentionally over-simplified. An important aspect
of the data analysis approach is neglected, which does not reflect the complexity and
subtleties of the data analyst’s work [9]. A method that does not work well if applied
in a standard way without knowledge of the substantive context might perform better in
concrete situations, hence reducing the relevance of comparison studies.
To conclude, neutral comparison studies are often considered as less exciting than
projects on new methods by both researchers and journal editors – but not by readers.
They can neither be expected to always give the best answer to the question “which
method should I use to analyze my data set” nor reflect a real data analysis approach
that takes the substantive context into account. However, we believe that they may play a
crucial role to make the evaluation of existing methods more rational and to establish stan-
dards on a scientific basis. They certainly deserve more consideration than is currently
the case in the literature.
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Table 1: Overview: Published articles dealing with supervised classification prob-
lems in the period from 2010 to 2012.
Journal # Articles
Bioinformatics (BI) 16
Bioinformatics (until Volume 28 Issue 23, 2012) 6
BMC Bioinformatics (until Volume 13 – October 15, 2012) 10
Computational Statistics (CS) 17
Computational Statistics (until Volume 27, Issue 4, 2012) 4
Computational Statistics & Data Analysis (until Volume 56, Issue 12, 2012) 11
Journal of Computational and Graphical Statistics (until Volume 21, Issue 3, 2012) 2
Machine Learning (ML) 26
Journal of Machine Learning Research (until Volume 13, 2012) 15
Machine Learning (until Volume 89, Issue 1-2, 2012) 11
Total 59
17
Table 2: Examples for the three winner categories.
Category Examples
W1 superior
“always leads to improved prediction performance”
“the proposed method efficiently reduces prediction errors”
“the proposed algorithm is superior to existing methods”
W2 competitive +
“has the additional computational advantage”
“a more cost-efficient classifier that is at least as good, and sometimes better”
“reduction in computational time for training the algorithm”
W3 competitive −
“the drawback of our method is that”
“can be more expensive to compute”
“further research might be needed”
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 Articles published between 
2010 – 2012 
 
Comparison of at least 2 methods and evaluation on real data 
 
New method 
(N=43) 
Number of data sets (1), considered methods (2)  
and accuracy measurements (3)? 
Clear winner(s) (5)?  
Winner(s) mentioned in abstract (6)?  
Questions: 
Target Population 
 
Classification / Regression Problems 
 
 (N=59) 
 
(N = 5100) 
 
(N=55) 
 
Population 
 
Comparison 
(N=12) 
(4) 
Which type of winner(s) (7)? 
Several variants (8)? 
Figure 1: Flowchart of the paper selection process and recorded features. The num-
bers in parentheses refer to the numbering of the recorded features defined in the Methods
section.
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Figure 2: Overview of selected papers and selection criteria. The top panel shows the
global results for all papers relevant to the respective question (either all 59 papers or
the 55 papers satisfying Condition 3), while the bottom panel shows the results stratified
by research field (bioinformatics: BI, computational statistics: CS and machine learning:
ML). (A) and (E): Does the paper include a comparison of two or more methods?; (B)
and (F): Does the paper include an evaluation on real data?; (C) and (G): Does the paper
fulfill Condition 3?; (D) and (H): Does the paper present a new method?
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Figure 3: Number of data sets, methods and accuracy measurements. The top panel
depicts the results for all 55 papers, the results in the middle panel are stratified by research
field (bioinformatics: BI, computational statistics: CS and machine learning: ML), and
the bottom panel differentiates between “comparison” and “new method” papers. (A),
(D) and (G) show the number of data sets, (B), (E) and (H) the number of methods, (C),
(F) and (I) the number of accuracy measurements.
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Figure 4: Reporting of winners. The top panel shows the global results for all papers
relevant to the respective question (either all 55 papers satisfying Condition 3 or the 43
papers on new methods), while the bottom panel shows the results stratified by research
field (bioinformatics: BI, computational statistics: CS and machine learning: ML). (A)
and (E): Are there clear winner(s)?; (B) and (F): Are the winner(s) mentioned in the
abstract?; (C) and (G): Which type of winner(s) (W1,W2, or W3) is identified? (for the
43 papers on new methods only); (D) and (H): Is the new method presented in several
variants? (for the 43 paper on new methods only)
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